Hock C

References (3)

Title : A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease - Wilkinson_2002_Int.J.Clin.Pract_56_441
Author(s) : Wilkinson DG , Passmore AP , Bullock R , Hopker SW , Smith R , Potocnik FC , Maud CM , Engelbrecht I , Hock C , Ieni JR , Bahra RS
Ref : Int J Clin Pract , 56 :441 , 2002
Abstract : Wilkinson_2002_Int.J.Clin.Pract_56_441
ESTHER : Wilkinson_2002_Int.J.Clin.Pract_56_441
PubMedSearch : Wilkinson_2002_Int.J.Clin.Pract_56_441
PubMedID: 12166542

Title : [Alzheimer dementia] - Hock_2000_Praxis.(Bern.1994)_89_529
Author(s) : Hock C , Nitsch RM
Ref : Praxis (Bern 1994) , 89 :529 , 2000
Abstract : Hock_2000_Praxis.(Bern.1994)_89_529
ESTHER : Hock_2000_Praxis.(Bern.1994)_89_529
PubMedSearch : Hock_2000_Praxis.(Bern.1994)_89_529
PubMedID: 10776055

Title : Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's disease - Hock_2000_Ann.N.Y.Acad.Sci_920_285
Author(s) : Hock C , Maddalena A , Heuser I , Naber D , Oertel W , von der Kammer H , Wienrich M , Raschig A , Deng M , Growdon JH , Nitsch RM
Ref : Annals of the New York Academy of Sciences , 920 :285 , 2000
Abstract : Hock_2000_Ann.N.Y.Acad.Sci_920_285
ESTHER : Hock_2000_Ann.N.Y.Acad.Sci_920_285
PubMedSearch : Hock_2000_Ann.N.Y.Acad.Sci_920_285
PubMedID: 11193166